HOME
PORTFOLIO
TEAM
FAQ
DIFFERENTIATION
SURF BREAK
START-UP GATEWAY
More
Carlsmed (NASDAQ:CARL) reported second-quarter 2026 revenue of $18.9 million, up 57% from $12.1 million a year earlier, as growth in its aprevo lumbar platform and contributions from its newer cervical offering lifted procedure volumes.
Portfolio Company
Regard has been named to TIME's World's Top HealthTech Companies of 2026 ! ...
Time
Sep 16, 2026
Skin Analytics Selected as Time's Worlds Top Health Tech Companies 2026 ...
Trusted Health Collaborates to Bring CareCast Workforce Demand Forecasting to He ...
Trusted
Sep 10, 2026
